JP Morgan Maintains Neutral on Haemonetics, Raises Price Target to $86

Benzinga Newsdesk www.benzinga.com Neutral 52.4%

Neg 0% Neu 52.4% Pos 0%

JP Morgan analyst Allen Gong maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $62 to $86.